Evaluation of the Impact of the Repositioning Schedule Adapted to the Risk of Pressure Ulcer of Patients in Intensive Care Unit
Sponsor: Assistance Publique - Hôpitaux de Paris
A NA clinical study on Ischemic and Ischemic Ulcer, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
9 versions recorded-
Mar 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Nov 2022 — Dec 2023 [monthly]
Recruiting NA
-
Sep 2021 — Nov 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Paris, France